NPC's John O'Brien to Speak at Pharma & Patient USA 2023

  • November 16, 2023 - 1:00pm - 2:00pm

NPC's John O'Brien will serve as a guest expert at an event hosted by Reuters Events, and will help unpack the potential impacts of the Inflation Reduction Act and how stakeholders can work to promote patient access to medicines. 

Reuters

NPC's President and CEO, John M. O'Brien, PharmD, MPH, will speak at a panel event during Pharma & Patient USA 2023, hosted by Reuters Events in Philadelphia, November 16 - 17, 2023.  

Thursday, November 16, 2023 | 1:20 p.m. - 1:40 p.m. ET

Session: Navigate the Inflation Reduction Act: Safeguarding Patient Access

  • Assess how IRA negotiations could delay launches and limit indications
  • Address intensified cost challenges for rare/orphan indications
  • Partner with HEOR experts to inform policy and balance access and affordability

Panelists: 

  • John O’Brien, President and Chief Executive Officer, National Pharmaceutical Council.
  • Dan Wygal, VP, US Corporate & Government Affairs, AstraZeneca

Learn more about the conference